Johnson & Johnson (NYSE:JNJ)

100.34
Delayed Data
As of Mar 27
 +0.20 / +0.20%
Today’s Change
95.10
Today|||52-Week Range
109.49
-4.05%
Year-to-Date
Dr Google assists in robotic surgery
Mar 27 / FT.com
This is Why Diabetes Treatment Costs Are Soaring
Mar 21 / MotleyFool.com
Google and Johnson & Johnson partner up for hi-tech surgery
Mar 27 / CNNMoney.com
80% of American Adults Will Suffer From This at Some Point in Their Lives
Mar 21 / MotleyFool.com
Biotech, Chips Stand Their Ground
Mar 27 / TheStreet.com
The charity that matches surplus medicine with acute need
Mar 19 / FT.com
Johnson & Johnson Teams With Google On Surgery Robot Development
Mar 27 / Benzinga
Pharmacyclics' Imbruvica Encourages in a Phase III Study - Analyst Blog
Mar 17 / Zacks.com
MedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook
Mar 26 / Zacks.com
Merck Reports Encouraging Data from Cardiovascular Study - Analyst Blog
Mar 17 / Zacks.com
Bad news: Stocks likely to fall further
Mar 26 / CNNMoney.com
Bristol-Myers Squibb Co. Is Back in the Hepatitis C Race
Mar 17 / MotleyFool.com
Zacks Industry Outlook Highlights: Johnson & Johnson and Medtronic - Press Releases
Mar 26 / Zacks.com
Stock Market News for March 17, 2015 - Market News
Mar 17 / Zacks.com
MedTech Industry Stock Outlook - March 2015 - Industry Outlook
Mar 25 / Zacks.com
Dementia research boosted by $100m venture capital fund
Mar 16 / FT.com
MedTech Industry Stock Outlook - March 2015 - Zacks Analyst Interviews
Mar 25 / Zacks.com
10 Great Stocks to Invest in for Your Retirement
Mar 15 / MotleyFool.com
MedTech Industry Stock Outlook - March 2015 - Zacks Analyst Interviews
Mar 25 / Zacks.com
The dollar is crushing other currencies
Mar 10 / CNNMoney.com
Facebook Inc (FB): Catalysts Driving The Stock
Mar 24 / Investing Channel
Sailing around the world in retirement: How we did it
Mar 09 / CNNMoney.com
Stocks to Cure What Ails on World TB Day - Analyst Blog
Mar 24 / Zacks.com
Going the extra mile to win a B#21bn deal
Mar 06 / FT.com
Why PETA Is Now a Domino's and Shake Shack Shareholder
Mar 24 / TheStreet.com
AbbVie wins three-way fight over Pharmacyclics
Mar 05 / FT.com
5 What-Ifs That Changed the Equation
Mar 23 / TheStreet.com
AbbVie joins the pharma chain reaction
Mar 05 / FT.com
Pharmacyclics chief to receive $3.6bn from takeover
Mar 23 / FT.com
Vertex climbs on drug approval hopes
Mar 05 / FT.com
3 Drugs Stocks Moving The Industry Upward
Mar 23 / TheStreet.com
Centerview builds record on pharma deals
Mar 05 / FT.com
8 Million Reasons to Buy and Hold
Mar 23 / TheStreet.com
Abbvie/Pharmacyclics: pay to play
Mar 05 / FT.com
Biotech Behemoth Gilead In Trouble After Flagship Drug Related Death
Mar 23 / Investing Channel
Q&A - why Abbvie had to strike $21bn Pharmacyclics deal
Mar 05 / FT.com
This Market Could Grow 6250% in 10 Years
Mar 23 / MotleyFool.com
J&J nears deal for cancer drugmaker
Mar 04 / FT.com
The Single Worst Practice of Medical Device Makers
Mar 22 / MotleyFool.com
These ads ran before ISIS videos
Mar 03 / CNNMoney.com
Confessions of a Value Investor Stuck in a High-Growth Industry
Mar 22 / MotleyFool.com
GSK-Novartis deal 'a model' for industry
Mar 02 / FT.com
Why Itbs Not Too Late to Buy Isis Pharmaceuticals Stock
Mar 21 / MotleyFool.com
The single best stock to own today
Feb 26 / CNNMoney.com
Drug Spending Is Soaring: 3 Takeaways You Can't Miss
Mar 21 / MotleyFool.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account